OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patients
Kovarik, J.; Zlabinger, G.J.; Wolfram, J.; Pecherstorfer, M.; Watschinger, B.; Traindl, O.; Pohanka, E.; Sonnleitner, A.; Ulrich, W.
Transplantation Proceedings 21(1 Part 2): 1748-1752
1989
ISSN/ISBN: 0041-1345 PMID: 2652572 Document Number: 338841
Document emailed within 1 workday
Related Documents
Costanzo-Nordin, M.R.; O'Sullivan, E.J.; Hubbell, E.A.; Zucker, M.J.; Pifarre, R.; McManus, B.M.; Winters, G.L.; Scanlon, P.J.; Robinson, J.A. 1989: Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience Journal of Heart Transplantation 8(4): 288-295Mirza, S.; Mahmud, S.N.; Abideen, Z.U.; Aziz, T.; Akhter, S.; Baloch, B.K. 2019: Overcoming the Immunological Barrier in Highly HLA Sensitized Renal Transplant Recipients - a Desensitization Experience from a Transplant Center in Pakistan JPMA. Journal of the Pakistan Medical Association 69(4): 584-587
Blagojević-Lazić, R.; Radivojević, D.; Andrejević, V.; Dzamić, Z.; Acimović, M.; Milutinović, D.; Djurasić, L.; Hadzi-Djokić, J. 2012: Malignant disease in renal transplant recipients--our experience Acta Chirurgica Iugoslavica 59(1): 49-51
Wong, K.M.; Bailey, R.R.; Lynn, K.L.; Robson, R.A.; Abbott, G.D. 1995: Pregnancy in renal transplant recipients: the Christchurch experience New Zealand Medical Journal 108(1000): 190-192
Ruangkanchanasetr, P.; Lauhawatana, B.; Leawseng, S.; Kitpanich, S.; Lumpaopong, A.; Thirakhupt, P. 2012: Malignancy in renal transplant recipients: a single-center experience in Thailand Journal of the Medical Association of Thailand 95(Suppl 5): S12-S16
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Stiller, C.; Keown, P. 1990: Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy Transplantation Proceedings 22(3): 1253-1254
Lundgren, G.; Groth, C.G.; Albrechtsen, D.; Brynger, H.; Flatmark, A.; Frödin, L.; Gugerli, U.; Gäbel, H.; Lindholm, A.; Persson, H. 1987: No difference in outcome between 314 nontransfused and 614 transfused cadaveric renal transplant recipients: the Scandinavian experience Clinical Transplants 1987: 249-255
Aufy, S.M.; Mahgoub, A.M.A.; Saadi, M.G.E.-D.; Adel Elmallawany, M. 2009: Serological detection of Toxoplasma gondii in chronic renal failure patients and renal transplant recipients Journal of the Egyptian Society of Parasitology 39(3): 943-950
Min, Z.L.; Zhao, M.; Zhu, Y.H.; Qi, J.; Wang, L.M.; Wang, Y.W. 1996: Experience with clinical use of Sandimmun Neoral in renal transplant patients Transplantation Proceedings 28(3): 1356-1357
Kim, H.C.; McMillan, C.W.; White, G.C.; Bergman, G.E.; Saidi, P. 1990: Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia B Seminars in Hematology 27(2 Suppl. 2): 30-35
Ivanovski, N.; Stojceva-Taneva, O.; Grozdanovski, R.; Boskovska, M.; Drueke, T.B.; Massy, Z.A. 2004: Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment Nephrologie 25(7): 301-303
Smith, C.L.; Hampton, E.M.; Pederson, J.A.; Pennington, L.R.; Bourne, D.W. 1994: Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients PharmacoTherapy 14(4): 471-481
Harmon, W.E.; Stablein, D.; Alexander, S.R.; Tejani, A. 1991: Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study Transplantation 51(2): 406-412
Gohar, S.A.; Khalil, R.Y.; Elaish, N.M.; Khedr, E.M.; Ahmed, M.S. 1995: Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients Journal of the Egyptian Public Health Association 70(5-6): 465-484
Kumar, D.; Fattah, H.; Kimball, P.M.; LeCorchick, S.; McDougan, F.A.; King, A.L.; Gupta, G. 2016: Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: a Single Center Experience Clinical Transplants 32: 143-151
Wang, Y-Yuan.; Zhang, M.; Lu, F-Ming.; Jiao, Z.; Qiu, X-Yan. 2012: CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients Chinese Medical Journal 125(23): 4233-4238
Abdelfatah, A.; Ducloux, D.; Toubin, Gérard.; Motte, Gérard.; Alber, D.; Chalopin, J-Marc. 2002: Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients Transplantation 73(4): 663-665
Grassi, F.R.; Pappalardo, S.; Baglìo, O.A.; Frateiacci, A.; Scortichini, A.; Papa, F.; De Benedittis, M.; Petruzzi, M. 2006: Gingival overgrowth in renal transplant recipients induced by pharmacological treatment. Review of the literature Minerva Stomatologica 55(1-2): 59-65
Kimball, P.M.; King, A. 2011: A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients Clinical Transplants 2011: 369-372